Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
Explore more from The Transmitter
Oligodendrocytes need mechanical cues to myelinate axons correctly
Without the mechanosensor TMEM63A, the cells cannot deposit the appropriate amount of insulation, according to a new study.
Oligodendrocytes need mechanical cues to myelinate axons correctly
Without the mechanosensor TMEM63A, the cells cannot deposit the appropriate amount of insulation, according to a new study.
Modern AI is simply no match for the complexity likely required for harboring consciousness, says Jaan Aru
He argues that our brain’s computations are of a completely different nature than any artificial intelligence because they take place across many spatial and temporal scales and are inextricably entwined with biological materials.
Modern AI is simply no match for the complexity likely required for harboring consciousness, says Jaan Aru
He argues that our brain’s computations are of a completely different nature than any artificial intelligence because they take place across many spatial and temporal scales and are inextricably entwined with biological materials.
Interneurons’ role in epilepsy, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 9 February.
Interneurons’ role in epilepsy, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 9 February.